Kadimastem to Collaborate with Merck Serono to Advance Combined...

Israeli biotechnology company Kadimastem reports that it has signed a collaboration agreement with Merck to carry out drug screening in the neurodegenerative diseases space for multiple sclerosis , and potential other neurodegenerative diseases.

http://ift.tt/UMTVZ7